Current Drug Targets
Volume 21, 16 Issues, 2020
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Drug Targets, Volume 6 - Number 6
Proteomics in Acute Myelogenous Leukaemia (AML): Methodological Strategies and Identification of Protein Targets for Novel Antileukaemic Therapy
, 6(6): 631 - 646G. Sjoholt, N. Anensen, L. Wergeland, E. Mc Cormack, O. Bruserud and B. T. Gjertsen
DOI: 10.2174/1389450054863671
Ribozymes, DNAzymes and Small Interfering RNAs as Therapeutics
, 6(6): 647 - 653M. Sioud and P. O. Iversen
DOI: 10.2174/1389450054863653
Protein Kinase A (PKA) - A Potential Target for Therapeutic Intervention of Dysfunctional Immune Cells
, 6(6): 655 - 664B. S. Skalhegg, A. Funderud, H. H. Henanger, T. T. Hafte, A. C. Larsen, A.- K. Kvissel, S. Eikvar and S. Orstavik
DOI: 10.2174/1389450054863644
Decreasing the Metastatic Potential in Cancers - Targeting the Heparan Sulfate Proteoglycans
, 6(6): 665 - 682K. Fjeldstad and S. O. Kolset
DOI: 10.2174/1389450054863662
Angiogenesis and Hemostasis in Hematological Neoplasias
, 6(6): 683 - 699H. Negaard, A. Dahm, P. M. Sandset, P. O. Iversen and B. Ostenstad
DOI: 10.2174/1389450054863699
Identification of New Targets for Therapy of Osteolytic Bone Disease in Multiple Myeloma
, 6(6): 701 - 711O. Hjertner, T. Standal, M. Borset, A. Sundan and A. Waage
DOI: 10.2174/1389450054863716
Editor-in-Chief
Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63
Advertisement
Webmaster Contact: info@benthamscience.net